UK's NICE updates its anemia treatment guidelines for CKD, lowering target Hb to 10-12 g/dL Print
NICE: In response, NICE has updated these recommendations and is now advising healthcare professionals treating anaemia of CKD with erythropoiesis stimulating agents to maintain the haemoglobin range between 10 and 12g/dl for adults, teenagers and children over two years, and to between 9.5 and 11.5 g/dl for those under two years of age.

...